118 related articles for article (PubMed ID: 10725871)
1. Potential use of serum CD44 as an indicator of tumour progression in acute leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1999 Dec; 17(4):161-8. PubMed ID: 10725871
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble CD44 in pediatric patients with acute leukemia.
Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.
De Rossi G; Marroni P; Paganuzzi M; Mauro FR; Tenca C; Zarcone D; Velardi A; Molica S; Grossi CE
Leukemia; 1997 Jan; 11(1):134-41. PubMed ID: 9001429
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.
Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K
Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma.
Sawant S; Ahire C; Dongre H; Joshi S; Jamghare S; Rane P; Kane S; Chaukar D
J Oral Pathol Med; 2018 Aug; 47(7):665-673. PubMed ID: 29752852
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S
Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients.
Stickeler E; Vogl FD; Denkinger T; Mobus VJ; Kreienberg R; Runnebaum IB
Int J Mol Med; 2000 Nov; 6(5):595-601. PubMed ID: 11029531
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma.
Harn HJ; Ho LI; Shyu RY; Yuan JS; Lin FG; Young TH; Liu CA; Tang HS; Lee WH
J Clin Gastroenterol; 1996 Mar; 22(2):107-10. PubMed ID: 8742647
[TBL] [Abstract][Full Text] [Related]
9. Serum osteopontin and CD44 levels in lymphoreticular malignancies in children.
Elli M; Dagdemir A; Bozkurt C; Pinarli FG; Duzgun A; Ozmen ZC; Ertem U; Acar S
Bratisl Lek Listy; 2012; 113(9):534-8. PubMed ID: 22979908
[TBL] [Abstract][Full Text] [Related]
10. Serum CD44 splice variants in cervical cancer patients.
Kainz C; Tempfer C; Winkler S; Sliutz G; Koelbl H; Reinthaller A
Cancer Lett; 1995 Apr; 90(2):231-4. PubMed ID: 7537626
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
[TBL] [Abstract][Full Text] [Related]
12. Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma.
Mäenpää H; Ristamäki R; Virtamo J; Franssila K; Albanes D; Joensuu H
Leuk Lymphoma; 2000 May; 37(5-6):585-92. PubMed ID: 11042519
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
Amirghofran Z; Asiaee E; Kamazani FM
Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia.
Jung K; Lein M; Weiss S; Schnorr D; Henke W; Loening S
Eur J Cancer; 1996 Apr; 32A(4):627-30. PubMed ID: 8695265
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
16. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
17. Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features.
Takigawa N; Segawa Y; Mandai K; Takata I; Fujimoto N
Lung Cancer; 1997 Oct; 18(2):147-57. PubMed ID: 9316006
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
19. Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors.
Ahmed MI; Hassab HM
Egypt J Immunol; 2008; 15(2):101-11. PubMed ID: 20306693
[TBL] [Abstract][Full Text] [Related]
20. Serum CD44 in non-Hodgkin's lymphoma.
Ristamäki R; Joensuu H; Jalkanen S
Leuk Lymphoma; 1999 May; 33(5-6):433-40. PubMed ID: 10342571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
